nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.144	0.31	CbGbCtD
Zaleplon—CYP3A7—Sorafenib—liver cancer	0.144	0.31	CbGbCtD
Zaleplon—CYP3A5—Sorafenib—liver cancer	0.108	0.233	CbGbCtD
Zaleplon—CYP3A4—Sorafenib—liver cancer	0.0422	0.0908	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—liver cancer	0.0256	0.0551	CbGbCtD
Zaleplon—Fluid retention—Doxorubicin—liver cancer	0.00102	0.00238	CcSEcCtD
Zaleplon—Hypertonia—Epirubicin—liver cancer	0.00102	0.00238	CcSEcCtD
Zaleplon—Vaginal infection—Doxorubicin—liver cancer	0.00101	0.00237	CcSEcCtD
Zaleplon—Abnormal vision—Epirubicin—liver cancer	0.00101	0.00237	CcSEcCtD
Zaleplon—Neuropathy—Doxorubicin—liver cancer	0.00101	0.00236	CcSEcCtD
Zaleplon—Mental disability—Epirubicin—liver cancer	0.00101	0.00235	CcSEcCtD
Zaleplon—Dyspnoea—Sorafenib—liver cancer	0.000997	0.00234	CcSEcCtD
Zaleplon—Dry eye—Doxorubicin—liver cancer	0.00099	0.00232	CcSEcCtD
Zaleplon—Lymphadenopathy—Epirubicin—liver cancer	0.000986	0.00231	CcSEcCtD
Zaleplon—Dyspepsia—Sorafenib—liver cancer	0.000984	0.00231	CcSEcCtD
Zaleplon—Oesophagitis—Doxorubicin—liver cancer	0.000979	0.00229	CcSEcCtD
Zaleplon—Rash maculo-papular—Doxorubicin—liver cancer	0.000974	0.00228	CcSEcCtD
Zaleplon—Decreased appetite—Sorafenib—liver cancer	0.000972	0.00228	CcSEcCtD
Zaleplon—Thrombophlebitis—Epirubicin—liver cancer	0.000971	0.00228	CcSEcCtD
Zaleplon—Ecchymosis—Doxorubicin—liver cancer	0.000969	0.00227	CcSEcCtD
Zaleplon—Mouth ulceration—Doxorubicin—liver cancer	0.000969	0.00227	CcSEcCtD
Zaleplon—Bladder pain—Doxorubicin—liver cancer	0.000969	0.00227	CcSEcCtD
Zaleplon—Diabetes mellitus—Epirubicin—liver cancer	0.000967	0.00226	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Sorafenib—liver cancer	0.000965	0.00226	CcSEcCtD
Zaleplon—Photosensitivity—Epirubicin—liver cancer	0.000958	0.00224	CcSEcCtD
Zaleplon—Pain—Sorafenib—liver cancer	0.000956	0.00224	CcSEcCtD
Zaleplon—Constipation—Sorafenib—liver cancer	0.000956	0.00224	CcSEcCtD
Zaleplon—Vascular purpura—Epirubicin—liver cancer	0.00094	0.0022	CcSEcCtD
Zaleplon—Hypertonia—Doxorubicin—liver cancer	0.000939	0.0022	CcSEcCtD
Zaleplon—Eczema—Epirubicin—liver cancer	0.000936	0.00219	CcSEcCtD
Zaleplon—Abnormal vision—Doxorubicin—liver cancer	0.000935	0.00219	CcSEcCtD
Zaleplon—Eye pain—Epirubicin—liver cancer	0.000931	0.00218	CcSEcCtD
Zaleplon—Mental disability—Doxorubicin—liver cancer	0.00093	0.00218	CcSEcCtD
Zaleplon—Gastrointestinal pain—Sorafenib—liver cancer	0.000914	0.00214	CcSEcCtD
Zaleplon—Lymphadenopathy—Doxorubicin—liver cancer	0.000912	0.00214	CcSEcCtD
Zaleplon—Thrombophlebitis—Doxorubicin—liver cancer	0.000899	0.00211	CcSEcCtD
Zaleplon—Increased appetite—Epirubicin—liver cancer	0.000895	0.0021	CcSEcCtD
Zaleplon—Diabetes mellitus—Doxorubicin—liver cancer	0.000894	0.0021	CcSEcCtD
Zaleplon—Urticaria—Sorafenib—liver cancer	0.000888	0.00208	CcSEcCtD
Zaleplon—Photosensitivity—Doxorubicin—liver cancer	0.000886	0.00208	CcSEcCtD
Zaleplon—Abdominal pain—Sorafenib—liver cancer	0.000884	0.00207	CcSEcCtD
Zaleplon—Body temperature increased—Sorafenib—liver cancer	0.000884	0.00207	CcSEcCtD
Zaleplon—Dermatitis bullous—Epirubicin—liver cancer	0.00088	0.00206	CcSEcCtD
Zaleplon—Purpura—Epirubicin—liver cancer	0.000872	0.00204	CcSEcCtD
Zaleplon—Vascular purpura—Doxorubicin—liver cancer	0.00087	0.00204	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Epirubicin—liver cancer	0.000869	0.00204	CcSEcCtD
Zaleplon—Eczema—Doxorubicin—liver cancer	0.000866	0.00203	CcSEcCtD
Zaleplon—Eye pain—Doxorubicin—liver cancer	0.000862	0.00202	CcSEcCtD
Zaleplon—Hypoglycaemia—Epirubicin—liver cancer	0.000862	0.00202	CcSEcCtD
Zaleplon—Diplopia—Epirubicin—liver cancer	0.000841	0.00197	CcSEcCtD
Zaleplon—Osteoarthritis—Epirubicin—liver cancer	0.000841	0.00197	CcSEcCtD
Zaleplon—Increased appetite—Doxorubicin—liver cancer	0.000828	0.00194	CcSEcCtD
Zaleplon—Migraine—Epirubicin—liver cancer	0.000828	0.00194	CcSEcCtD
Zaleplon—Affect lability—Epirubicin—liver cancer	0.000828	0.00194	CcSEcCtD
Zaleplon—Dermatitis bullous—Doxorubicin—liver cancer	0.000814	0.00191	CcSEcCtD
Zaleplon—Face oedema—Epirubicin—liver cancer	0.000812	0.0019	CcSEcCtD
Zaleplon—Purpura—Doxorubicin—liver cancer	0.000807	0.00189	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000804	0.00188	CcSEcCtD
Zaleplon—Asthenia—Sorafenib—liver cancer	0.000802	0.00188	CcSEcCtD
Zaleplon—Hypoglycaemia—Doxorubicin—liver cancer	0.000797	0.00187	CcSEcCtD
Zaleplon—Mood swings—Epirubicin—liver cancer	0.000797	0.00187	CcSEcCtD
Zaleplon—Pruritus—Sorafenib—liver cancer	0.000791	0.00185	CcSEcCtD
Zaleplon—Ataxia—Epirubicin—liver cancer	0.000791	0.00185	CcSEcCtD
Zaleplon—Diplopia—Doxorubicin—liver cancer	0.000778	0.00182	CcSEcCtD
Zaleplon—Osteoarthritis—Doxorubicin—liver cancer	0.000778	0.00182	CcSEcCtD
Zaleplon—Liver function test abnormal—Epirubicin—liver cancer	0.000776	0.00182	CcSEcCtD
Zaleplon—Dry skin—Epirubicin—liver cancer	0.000771	0.00181	CcSEcCtD
Zaleplon—Orthostatic hypotension—Epirubicin—liver cancer	0.000768	0.0018	CcSEcCtD
Zaleplon—Migraine—Doxorubicin—liver cancer	0.000766	0.00179	CcSEcCtD
Zaleplon—Affect lability—Doxorubicin—liver cancer	0.000766	0.00179	CcSEcCtD
Zaleplon—Breast disorder—Epirubicin—liver cancer	0.00076	0.00178	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000757	0.00177	CcSEcCtD
Zaleplon—Face oedema—Doxorubicin—liver cancer	0.000751	0.00176	CcSEcCtD
Zaleplon—Gastritis—Epirubicin—liver cancer	0.000744	0.00174	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000742	0.00174	CcSEcCtD
Zaleplon—Muscular weakness—Epirubicin—liver cancer	0.000742	0.00174	CcSEcCtD
Zaleplon—Dizziness—Sorafenib—liver cancer	0.000739	0.00173	CcSEcCtD
Zaleplon—Mood swings—Doxorubicin—liver cancer	0.000737	0.00173	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—liver cancer	0.000732	0.00171	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—liver cancer	0.000727	0.0017	CcSEcCtD
Zaleplon—Asthma—Epirubicin—liver cancer	0.000727	0.0017	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—liver cancer	0.00072	0.00169	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—liver cancer	0.000718	0.00168	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—liver cancer	0.000713	0.00167	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—liver cancer	0.000711	0.00166	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—liver cancer	0.000708	0.00166	CcSEcCtD
Zaleplon—Rash—Sorafenib—liver cancer	0.000705	0.00165	CcSEcCtD
Zaleplon—Dermatitis—Sorafenib—liver cancer	0.000704	0.00165	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—liver cancer	0.000703	0.00165	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000701	0.00164	CcSEcCtD
Zaleplon—Headache—Sorafenib—liver cancer	0.000701	0.00164	CcSEcCtD
Zaleplon—Bronchitis—Epirubicin—liver cancer	0.000699	0.00164	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—liver cancer	0.000689	0.00161	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—liver cancer	0.000686	0.00161	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000686	0.00161	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—liver cancer	0.00068	0.00159	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—liver cancer	0.000672	0.00158	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—liver cancer	0.000672	0.00158	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—liver cancer	0.000671	0.00157	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—liver cancer	0.000666	0.00156	CcSEcCtD
Zaleplon—Nausea—Sorafenib—liver cancer	0.000664	0.00156	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—liver cancer	0.000663	0.00155	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—liver cancer	0.000661	0.00155	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—liver cancer	0.000657	0.00154	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—liver cancer	0.000656	0.00154	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—liver cancer	0.000655	0.00153	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—liver cancer	0.000652	0.00153	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—liver cancer	0.000647	0.00152	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—liver cancer	0.000635	0.00149	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—liver cancer	0.000632	0.00148	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—liver cancer	0.00063	0.00148	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—liver cancer	0.000629	0.00147	CcSEcCtD
Zaleplon—Sweating—Epirubicin—liver cancer	0.000621	0.00146	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—liver cancer	0.000621	0.00146	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—liver cancer	0.000618	0.00145	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—liver cancer	0.000614	0.00144	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—liver cancer	0.000613	0.00144	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—liver cancer	0.000612	0.00143	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—liver cancer	0.000611	0.00143	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—liver cancer	0.000608	0.00143	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—liver cancer	0.000607	0.00142	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—liver cancer	0.000603	0.00141	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—liver cancer	0.000588	0.00138	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—liver cancer	0.000584	0.00137	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—liver cancer	0.000583	0.00137	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—liver cancer	0.000579	0.00136	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—liver cancer	0.000575	0.00135	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—liver cancer	0.000573	0.00134	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—liver cancer	0.000572	0.00134	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—liver cancer	0.000567	0.00133	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—liver cancer	0.000566	0.00132	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—liver cancer	0.000561	0.00131	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—liver cancer	0.000544	0.00127	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—liver cancer	0.000542	0.00127	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—liver cancer	0.000536	0.00125	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—liver cancer	0.00053	0.00124	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—liver cancer	0.000525	0.00123	CcSEcCtD
Zaleplon—Chills—Epirubicin—liver cancer	0.000522	0.00122	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—liver cancer	0.000519	0.00122	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—liver cancer	0.000514	0.0012	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—liver cancer	0.00051	0.00119	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—liver cancer	0.000506	0.00119	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—liver cancer	0.000503	0.00118	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—liver cancer	0.000502	0.00118	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—liver cancer	0.000499	0.00117	CcSEcCtD
Zaleplon—Tension—Epirubicin—liver cancer	0.000497	0.00116	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—liver cancer	0.000496	0.00116	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—liver cancer	0.000492	0.00115	CcSEcCtD
Zaleplon—Back pain—Epirubicin—liver cancer	0.00049	0.00115	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—liver cancer	0.000486	0.00114	CcSEcCtD
Zaleplon—Chills—Doxorubicin—liver cancer	0.000483	0.00113	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—liver cancer	0.000476	0.00111	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—liver cancer	0.000472	0.0011	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—liver cancer	0.00047	0.0011	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—liver cancer	0.000469	0.0011	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—liver cancer	0.000468	0.0011	CcSEcCtD
Zaleplon—Agitation—Epirubicin—liver cancer	0.000465	0.00109	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—liver cancer	0.000462	0.00108	CcSEcCtD
Zaleplon—Tension—Doxorubicin—liver cancer	0.00046	0.00108	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—liver cancer	0.000459	0.00107	CcSEcCtD
Zaleplon—Malaise—Epirubicin—liver cancer	0.000457	0.00107	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—liver cancer	0.000455	0.00107	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—liver cancer	0.000455	0.00107	CcSEcCtD
Zaleplon—Syncope—Epirubicin—liver cancer	0.000454	0.00106	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—liver cancer	0.000453	0.00106	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—liver cancer	0.000447	0.00105	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—liver cancer	0.000445	0.00104	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—liver cancer	0.000437	0.00102	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—liver cancer	0.000435	0.00102	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—liver cancer	0.000433	0.00101	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—liver cancer	0.000431	0.00101	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—liver cancer	0.000431	0.00101	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—liver cancer	0.000431	0.00101	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—liver cancer	0.000431	0.00101	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—liver cancer	0.00043	0.00101	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000428	0.001	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—liver cancer	0.000426	0.000998	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—liver cancer	0.000423	0.00099	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—liver cancer	0.000422	0.000988	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—liver cancer	0.000421	0.000986	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—liver cancer	0.00042	0.000984	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—liver cancer	0.000417	0.000976	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—liver cancer	0.000414	0.00097	CcSEcCtD
Zaleplon—Oedema—Epirubicin—liver cancer	0.000413	0.000968	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—liver cancer	0.000413	0.000968	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—liver cancer	0.000412	0.000965	CcSEcCtD
Zaleplon—Shock—Epirubicin—liver cancer	0.000407	0.000953	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—liver cancer	0.000405	0.00095	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—liver cancer	0.000405	0.000948	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—liver cancer	0.000403	0.000945	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—liver cancer	0.000401	0.00094	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—liver cancer	0.0004	0.000936	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—liver cancer	0.000399	0.000935	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—liver cancer	0.000399	0.000935	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—liver cancer	0.000399	0.000935	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—liver cancer	0.000398	0.000931	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000396	0.000928	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—liver cancer	0.000394	0.000923	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—liver cancer	0.000394	0.000923	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—liver cancer	0.00039	0.000914	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—liver cancer	0.000386	0.000905	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—liver cancer	0.000386	0.000903	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—liver cancer	0.000382	0.000896	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—liver cancer	0.000382	0.000896	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000377	0.000882	CcSEcCtD
Zaleplon—Shock—Doxorubicin—liver cancer	0.000376	0.000881	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—liver cancer	0.000375	0.000879	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—liver cancer	0.000374	0.000876	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—liver cancer	0.000373	0.000874	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—liver cancer	0.000371	0.00087	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—liver cancer	0.000371	0.000869	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—liver cancer	0.00037	0.000866	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—liver cancer	0.000368	0.000863	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—liver cancer	0.000367	0.000861	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—liver cancer	0.000364	0.000854	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—liver cancer	0.000364	0.000852	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—liver cancer	0.000359	0.000842	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—liver cancer	0.000357	0.000837	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—liver cancer	0.000357	0.000836	CcSEcCtD
Zaleplon—Constipation—Epirubicin—liver cancer	0.000353	0.000828	CcSEcCtD
Zaleplon—Pain—Epirubicin—liver cancer	0.000353	0.000828	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000348	0.000816	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—liver cancer	0.000346	0.00081	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—liver cancer	0.000343	0.000804	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—liver cancer	0.000341	0.000799	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—liver cancer	0.000341	0.000798	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—liver cancer	0.00034	0.000796	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—liver cancer	0.000338	0.000792	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—liver cancer	0.000337	0.000789	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—liver cancer	0.000332	0.000779	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00033	0.000773	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—liver cancer	0.000328	0.000769	CcSEcCtD
Zaleplon—Pain—Doxorubicin—liver cancer	0.000327	0.000766	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—liver cancer	0.000327	0.000766	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—liver cancer	0.000327	0.000765	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—liver cancer	0.000327	0.000765	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—liver cancer	0.000315	0.000738	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—liver cancer	0.000313	0.000733	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—liver cancer	0.000304	0.000712	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—liver cancer	0.000302	0.000708	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—liver cancer	0.000302	0.000708	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—liver cancer	0.000297	0.000695	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—liver cancer	0.000292	0.000685	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—liver cancer	0.000274	0.000643	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—liver cancer	0.000273	0.00064	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—liver cancer	0.000271	0.000634	CcSEcCtD
Zaleplon—Rash—Epirubicin—liver cancer	0.000261	0.00061	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—liver cancer	0.00026	0.00061	CcSEcCtD
Zaleplon—Headache—Epirubicin—liver cancer	0.000259	0.000607	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—liver cancer	0.000253	0.000592	CcSEcCtD
Zaleplon—Nausea—Epirubicin—liver cancer	0.000245	0.000575	CcSEcCtD
Zaleplon—Rash—Doxorubicin—liver cancer	0.000241	0.000565	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—liver cancer	0.000241	0.000564	CcSEcCtD
Zaleplon—Headache—Doxorubicin—liver cancer	0.00024	0.000561	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—liver cancer	0.000227	0.000532	CcSEcCtD
Zaleplon—AOX1—Metabolism—NAT2—liver cancer	0.000139	0.00128	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000139	0.00128	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CASP3—liver cancer	0.000138	0.00127	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—RAF1—liver cancer	0.000138	0.00126	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000135	0.00124	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—JUN—liver cancer	0.000134	0.00123	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000134	0.00123	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALDOB—liver cancer	0.000134	0.00123	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CTNNB1—liver cancer	0.000133	0.00122	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000132	0.00122	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000132	0.00121	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTM1—liver cancer	0.000131	0.0012	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000131	0.0012	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000129	0.00119	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	0.000129	0.00118	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—UGDH—liver cancer	0.000128	0.00118	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CRABP1—liver cancer	0.000128	0.00117	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000127	0.00117	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK8—liver cancer	0.000127	0.00117	CbGpPWpGaD
Zaleplon—AOX1—Disease—ADAM17—liver cancer	0.000126	0.00116	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000124	0.00114	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP1A1—liver cancer	0.000124	0.00114	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000123	0.00113	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	0.000122	0.00112	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000122	0.00112	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000121	0.00112	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—EPT1—liver cancer	0.000121	0.00111	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—RAF1—liver cancer	0.00012	0.0011	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000119	0.00109	CbGpPWpGaD
Zaleplon—AOX1—Disease—PSMA4—liver cancer	0.000119	0.00109	CbGpPWpGaD
Zaleplon—AOX1—Disease—PSMD10—liver cancer	0.000119	0.00109	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000118	0.00109	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—BRAF—liver cancer	0.000117	0.00107	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000116	0.00107	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—liver cancer	0.000116	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Disease—GOT2—liver cancer	0.000115	0.00106	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TAT—liver cancer	0.000114	0.00105	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HPGDS—liver cancer	0.000111	0.00102	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000111	0.00102	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000111	0.00102	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—BRAF—liver cancer	0.000109	0.001	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—BRAF—liver cancer	0.000109	0.000998	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000108	0.000997	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000108	0.000993	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000107	0.000986	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—BRAF—liver cancer	0.000107	0.00098	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000104	0.000955	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000103	0.000949	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000103	0.000948	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.000102	0.000933	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000101	0.000932	CbGpPWpGaD
Zaleplon—AOX1—Disease—GOT1—liver cancer	9.96e-05	0.000915	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PSMD10—liver cancer	9.94e-05	0.000913	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PSMA4—liver cancer	9.94e-05	0.000913	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—HPGDS—liver cancer	9.84e-05	0.000904	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—RAF1—liver cancer	9.74e-05	0.000895	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GOT2—liver cancer	9.67e-05	0.000888	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—liver cancer	9.64e-05	0.000886	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	9.44e-05	0.000868	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—BRAF—liver cancer	9.32e-05	0.000857	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	9.31e-05	0.000855	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UGDH—liver cancer	9.27e-05	0.000852	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRKCE—liver cancer	9.19e-05	0.000845	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—RAF1—liver cancer	9.13e-05	0.000839	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2E1—liver cancer	9.09e-05	0.000835	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—RAF1—liver cancer	9.07e-05	0.000833	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	9.04e-05	0.00083	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—liver cancer	8.98e-05	0.000825	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—RAF1—liver cancer	8.91e-05	0.000818	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	8.87e-05	0.000815	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	8.82e-05	0.00081	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.73e-05	0.000802	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EPT1—liver cancer	8.72e-05	0.000801	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.67e-05	0.000797	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.51e-05	0.000782	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYCS—liver cancer	8.5e-05	0.000781	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—HRAS—liver cancer	8.48e-05	0.000779	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GGT1—liver cancer	8.34e-05	0.000767	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GOT1—liver cancer	8.34e-05	0.000767	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TAT—liver cancer	8.26e-05	0.000759	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	8.09e-05	0.000744	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2E1—liver cancer	8.02e-05	0.000737	CbGpPWpGaD
Zaleplon—AOX1—Disease—H2AFX—liver cancer	8.02e-05	0.000736	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	7.91e-05	0.000727	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	7.79e-05	0.000716	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—RAF1—liver cancer	7.78e-05	0.000715	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CPT1B—liver cancer	7.77e-05	0.000714	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GLUL—liver cancer	7.77e-05	0.000714	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.71e-05	0.000708	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—liver cancer	7.5e-05	0.000689	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NR1H4—liver cancer	7.49e-05	0.000688	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—liver cancer	7.49e-05	0.000688	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	7.44e-05	0.000684	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—liver cancer	7.39e-05	0.000679	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA3—liver cancer	7.37e-05	0.000677	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GGT1—liver cancer	7.36e-05	0.000677	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	7.3e-05	0.000671	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—liver cancer	7.27e-05	0.000668	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	7.25e-05	0.000667	CbGpPWpGaD
Zaleplon—AOX1—Disease—TERT—liver cancer	7.25e-05	0.000666	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	7.12e-05	0.000655	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	7e-05	0.000643	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—liver cancer	6.89e-05	0.000633	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA4—liver cancer	6.74e-05	0.000619	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—liver cancer	6.61e-05	0.000608	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA2—liver cancer	6.56e-05	0.000603	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	6.56e-05	0.000603	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	6.53e-05	0.0006	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1A1—liver cancer	6.53e-05	0.0006	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.52e-05	0.000599	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	6.52e-05	0.000599	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	6.4e-05	0.000588	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTA1—liver cancer	6.33e-05	0.000582	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NAT2—liver cancer	6.26e-05	0.000575	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	6.23e-05	0.000572	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—liver cancer	6.11e-05	0.000561	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—liver cancer	6.09e-05	0.000559	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.08e-05	0.000558	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOB—liver cancer	6e-05	0.000552	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.99e-05	0.000551	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARA—liver cancer	5.97e-05	0.000549	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	5.79e-05	0.000532	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.76e-05	0.000529	CbGpPWpGaD
Zaleplon—AOX1—Disease—BRAF—liver cancer	5.74e-05	0.000527	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CRABP1—liver cancer	5.73e-05	0.000526	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.68e-05	0.000522	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CPT1B—liver cancer	5.62e-05	0.000516	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GLUL—liver cancer	5.62e-05	0.000516	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	5.59e-05	0.000514	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	5.43e-05	0.000499	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NR1H4—liver cancer	5.42e-05	0.000498	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	5.39e-05	0.000495	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—liver cancer	5.37e-05	0.000493	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—liver cancer	5.36e-05	0.000493	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA3—liver cancer	5.32e-05	0.000489	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—liver cancer	5.31e-05	0.000488	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	5.29e-05	0.000486	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	5.24e-05	0.000481	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—liver cancer	5.11e-05	0.00047	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—liver cancer	5.03e-05	0.000462	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HPGDS—liver cancer	5.01e-05	0.00046	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—liver cancer	4.99e-05	0.000459	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—liver cancer	4.94e-05	0.000454	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	4.91e-05	0.000451	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—liver cancer	4.9e-05	0.000451	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	4.88e-05	0.000448	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA4—liver cancer	4.87e-05	0.000447	CbGpPWpGaD
Zaleplon—AOX1—Disease—RAF1—liver cancer	4.79e-05	0.00044	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	4.79e-05	0.00044	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA2—liver cancer	4.75e-05	0.000436	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—liver cancer	4.68e-05	0.00043	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTOR—liver cancer	4.68e-05	0.00043	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	4.63e-05	0.000425	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA1—liver cancer	4.58e-05	0.000421	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAT2—liver cancer	4.53e-05	0.000416	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—liver cancer	4.5e-05	0.000413	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PSMA4—liver cancer	4.46e-05	0.00041	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PSMD10—liver cancer	4.46e-05	0.00041	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—liver cancer	4.44e-05	0.000408	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—liver cancer	4.39e-05	0.000403	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GOT2—liver cancer	4.34e-05	0.000399	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOB—liver cancer	4.34e-05	0.000399	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGDH—liver cancer	4.31e-05	0.000396	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—liver cancer	4.29e-05	0.000394	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	4.19e-05	0.000385	CbGpPWpGaD
Zaleplon—AOX1—Disease—CTNNB1—liver cancer	4.15e-05	0.000381	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CRABP1—liver cancer	4.14e-05	0.00038	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2E1—liver cancer	4.08e-05	0.000375	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—liver cancer	4.05e-05	0.000372	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EPT1—liver cancer	4.05e-05	0.000372	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—liver cancer	3.92e-05	0.00036	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TAT—liver cancer	3.84e-05	0.000353	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYCS—liver cancer	3.82e-05	0.000351	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GOT1—liver cancer	3.75e-05	0.000344	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GGT1—liver cancer	3.75e-05	0.000344	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HPGDS—liver cancer	3.62e-05	0.000332	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—liver cancer	3.62e-05	0.000332	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—liver cancer	3.37e-05	0.000309	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—liver cancer	3.36e-05	0.000309	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—liver cancer	3.35e-05	0.000308	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—liver cancer	3.32e-05	0.000305	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PSMA4—liver cancer	3.23e-05	0.000296	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PSMD10—liver cancer	3.23e-05	0.000296	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GOT2—liver cancer	3.14e-05	0.000288	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—liver cancer	3.11e-05	0.000285	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—liver cancer	3.09e-05	0.000284	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2E1—liver cancer	2.95e-05	0.000271	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—liver cancer	2.93e-05	0.000269	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—liver cancer	2.85e-05	0.000262	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYCS—liver cancer	2.76e-05	0.000254	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—liver cancer	2.73e-05	0.000251	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GGT1—liver cancer	2.71e-05	0.000249	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GOT1—liver cancer	2.71e-05	0.000249	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARA—liver cancer	2.68e-05	0.000246	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—liver cancer	2.64e-05	0.000242	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CPT1B—liver cancer	2.61e-05	0.00024	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GLUL—liver cancer	2.61e-05	0.00024	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—liver cancer	2.53e-05	0.000232	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NR1H4—liver cancer	2.52e-05	0.000231	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA3—liver cancer	2.48e-05	0.000227	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—liver cancer	2.43e-05	0.000224	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—liver cancer	2.4e-05	0.00022	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—liver cancer	2.39e-05	0.000219	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—liver cancer	2.33e-05	0.000214	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—liver cancer	2.3e-05	0.000211	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA4—liver cancer	2.26e-05	0.000208	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—liver cancer	2.24e-05	0.000205	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—liver cancer	2.22e-05	0.000204	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA2—liver cancer	2.21e-05	0.000203	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA1—liver cancer	2.13e-05	0.000196	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—liver cancer	2.12e-05	0.000195	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAT2—liver cancer	2.1e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—liver cancer	2.02e-05	0.000185	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOB—liver cancer	2.02e-05	0.000185	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—liver cancer	1.99e-05	0.000183	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—liver cancer	1.98e-05	0.000182	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—liver cancer	1.95e-05	0.000179	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARA—liver cancer	1.94e-05	0.000178	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CRABP1—liver cancer	1.92e-05	0.000177	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—liver cancer	1.76e-05	0.000162	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPGDS—liver cancer	1.68e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—liver cancer	1.66e-05	0.000153	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—liver cancer	1.6e-05	0.000147	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSMA4—liver cancer	1.5e-05	0.000138	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSMD10—liver cancer	1.5e-05	0.000138	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—liver cancer	1.46e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GOT2—liver cancer	1.46e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—liver cancer	1.44e-05	0.000132	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2E1—liver cancer	1.37e-05	0.000126	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYCS—liver cancer	1.28e-05	0.000118	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—liver cancer	1.27e-05	0.000117	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GGT1—liver cancer	1.26e-05	0.000116	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GOT1—liver cancer	1.26e-05	0.000116	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—liver cancer	1.13e-05	0.000104	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—liver cancer	1.12e-05	0.000102	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—liver cancer	1.07e-05	9.86e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—liver cancer	1.04e-05	9.55e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—liver cancer	9.85e-06	9.05e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—liver cancer	9.19e-06	8.44e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARA—liver cancer	9.01e-06	8.28e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—liver cancer	8.76e-06	8.05e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—liver cancer	7.76e-06	7.12e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—liver cancer	7.72e-06	7.09e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—liver cancer	7.45e-06	6.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—liver cancer	6.79e-06	6.23e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—liver cancer	6.7e-06	6.15e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—liver cancer	6.34e-06	5.82e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—liver cancer	5.91e-06	5.43e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—liver cancer	3.61e-06	3.31e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—liver cancer	2.95e-06	2.71e-05	CbGpPWpGaD
